Saikosaponin D inhibits proliferation of human osteosarcoma cells via the p53 signaling pathway

  • Authors:
    • Lin Zhao
    • Jing Li
    • Zhi‑Bo Sun
    • Chen Sun
    • Zhi‑Hong Yu
    • Xiao Guo
  • View Affiliations

  • Published online on: November 14, 2018     https://doi.org/10.3892/etm.2018.6969
  • Pages: 488-494
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Saikosaponin D (SSd), the major monomeric terpenoid extracted from Radix bupleuri, a traditional Chinese medicinal herb, exerts various pharmacological properties, including antitumor, anti‑inflammatory and antiviral. The present study aimed to investigate the role of SSd in human osteosarcoma (OS) cell growth. In the investigation MTS and EdU assays were applied and flow cytometric analyses of cell cycle and apoptosis were performed. Western blotting and reverse transcription‑quantitative polymerase chain reaction analyses were used to explore the underlying mechanisms of SSd on cell cycle transition and p53 signaling. Here, it was demonstrated that SSd administration at 80 µmol/l significantly inhibited 143B and MG‑63 proliferation. Furthermore, SSd significantly increased the percentage of 143B and MG‑63 cells in G0‑G1 phase and the number of apoptosis cells compared with the control group. Data further demonstrated that SSd treatment upregulated mRNA and protein levels of tumor protein 53 (p53) and its downstream targets, including p21, p27, B‑cell lymphoma‑2‑like protein 4 and cleaved caspase‑3, and downregulated mRNA and protein levels of cyclinD1. The results suggested that SSd was a functional tumor suppressor and inhibited OS proliferation via activation of the p53 signaling pathway and may be used in the treatment of osteosarcoma in future.
View Figures
View References

Related Articles

Journal Cover

January-2019
Volume 17 Issue 1

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhao L, Li J, Sun ZB, Sun C, Yu ZH and Guo X: Saikosaponin D inhibits proliferation of human osteosarcoma cells via the p53 signaling pathway. Exp Ther Med 17: 488-494, 2019.
APA
Zhao, L., Li, J., Sun, Z., Sun, C., Yu, Z., & Guo, X. (2019). Saikosaponin D inhibits proliferation of human osteosarcoma cells via the p53 signaling pathway. Experimental and Therapeutic Medicine, 17, 488-494. https://doi.org/10.3892/etm.2018.6969
MLA
Zhao, L., Li, J., Sun, Z., Sun, C., Yu, Z., Guo, X."Saikosaponin D inhibits proliferation of human osteosarcoma cells via the p53 signaling pathway". Experimental and Therapeutic Medicine 17.1 (2019): 488-494.
Chicago
Zhao, L., Li, J., Sun, Z., Sun, C., Yu, Z., Guo, X."Saikosaponin D inhibits proliferation of human osteosarcoma cells via the p53 signaling pathway". Experimental and Therapeutic Medicine 17, no. 1 (2019): 488-494. https://doi.org/10.3892/etm.2018.6969